BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21525382)

  • 1. Analyses of recombinant stereotypic IGHV3-21-encoded antibodies expressed in chronic lymphocytic leukemia.
    Ghia EM; Widhopf GF; Rassenti LZ; Kipps TJ
    J Immunol; 2011 Jun; 186(11):6338-44. PubMed ID: 21525382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.
    Widhopf GF; Goldberg CJ; Toy TL; Rassenti LZ; Wierda WG; Byrd JC; Keating MJ; Gribben JG; Rai KR; Kipps TJ
    Blood; 2008 Mar; 111(6):3137-44. PubMed ID: 17675554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.
    Ghia EM; Jain S; Widhopf GF; Rassenti LZ; Keating MJ; Wierda WG; Gribben JG; Brown JR; Rai KR; Byrd JC; Kay NE; Greaves AW; Kipps TJ
    Blood; 2008 May; 111(10):5101-8. PubMed ID: 18326815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.
    Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stella S; Guida G; Michel A; Crespo M; Laoutaris N; Montserrat E; Anagnostopoulos A; Dighiero G; Fassas A; Caligaris-Cappio F; Davi F
    Blood; 2005 Feb; 105(4):1678-85. PubMed ID: 15466924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia.
    Hadzidimitriou A; Darzentas N; Murray F; Smilevska T; Arvaniti E; Tresoldi C; Tsaftaris A; Laoutaris N; Anagnostopoulos A; Davi F; Ghia P; Rosenquist R; Stamatopoulos K; Belessi C
    Blood; 2009 Jan; 113(2):403-11. PubMed ID: 18948572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.
    Ghiotto F; Fais F; Albesiano E; Sison C; Valetto A; Gaidano G; Reinhardt J; Kolitz JE; Rai K; Allen SL; Ferrarini M; Chiorazzi N
    Mol Med; 2006; 12(11-12):300-8. PubMed ID: 17380195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia.
    Forconi F; Sozzi E; Rossi D; Sahota SS; Amato T; Raspadori D; Trentin L; Leoncini L; Gaidano G; Lauria F
    Haematologica; 2008 May; 93(5):697-705. PubMed ID: 18387977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.
    Stamatopoulos K; Belessi C; Hadzidimitriou A; Smilevska T; Kalagiakou E; Hatzi K; Stavroyianni N; Athanasiadou A; Tsompanakou A; Papadaki T; Kokkini G; Paterakis G; Saloum R; Laoutaris N; Anagnostopoulos A; Fassas A
    Blood; 2005 Nov; 106(10):3575-83. PubMed ID: 16076869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells.
    Widhopf GF; Kipps TJ
    J Immunol; 2001 Jan; 166(1):95-102. PubMed ID: 11123281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
    Schettino EW; Cerutti A; Chiorazzi N; Casali P
    J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cloning of Ig Fab genes of patients with chronic B lymphocytic leukemia and sequences analysis of their variable regions].
    Zhu H; Wang F; Zhang Y; Shen G
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):474-9. PubMed ID: 12482359
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Maity PC; Bilal M; Koning MT; Young M; van Bergen CAM; Renna V; Nicolò A; Datta M; Gentner-Göbel E; Barendse RS; Somers SF; de Groen RAL; Vermaat JSP; Steinbrecher D; Schneider C; Tausch E; Bittolo T; Bomben R; Mazzarello AN; Del Poeta G; Kroes WGM; van Wezel JT; Imkeller K; Busse CE; Degano M; Bakchoul T; Schulz AR; Mei H; Ghia P; Kotta K; Stamatopoulos K; Wardemann H; Zucchetto A; Chiorazzi N; Gattei V; Stilgenbauer S; Veelken H; Jumaa H
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4320-4327. PubMed ID: 32047037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for somatic selection of natural autoantibodies.
    Martin T; Duffy SF; Carson DA; Kipps TJ
    J Exp Med; 1992 Apr; 175(4):983-91. PubMed ID: 1552291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
    Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
    J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia.
    Ramsland PA; Brock CR; Moses J; Robinson BG; Edmundson AB; Raison RL
    Immunotechnology; 1999 Mar; 4(3-4):217-29. PubMed ID: 10231091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.
    Stamatopoulos B; Smith T; Crompot E; Pieters K; Clifford R; Mraz M; Robbe P; Burns A; Timbs A; Bruce D; Hillmen P; Meuleman N; Mineur P; Firescu R; Maerevoet M; De Wilde V; Efira A; Philippé J; Verhasselt B; Offner F; Sims D; Heger A; Dreau H; Schuh A
    Clin Cancer Res; 2018 Oct; 24(20):5048-5057. PubMed ID: 29945996
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen.
    Steininger C; Widhopf GF; Ghia EM; Morello CS; Vanura K; Sanders R; Spector D; Guiney D; Jäger U; Kipps TJ
    Blood; 2012 Mar; 119(10):2293-301. PubMed ID: 22234695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope.
    Que X; Widhopf GF; Amir S; Hartvigsen K; Hansen LF; Woelkers D; Tsimikas S; Binder CJ; Kipps TJ; Witztum JL
    PLoS One; 2013; 8(6):e65203. PubMed ID: 23840319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL.
    Forconi F; Potter KN; Wheatley I; Darzentas N; Sozzi E; Stamatopoulos K; Mockridge CI; Packham G; Stevenson FK
    Blood; 2010 Jan; 115(1):71-7. PubMed ID: 19887677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.